Does cold extraction always preserve more terpenes than hot extraction?

Generally yes, but it depends on the specific method and solvent. Cryogenic ethanol and ice-water separation techniques are designed to reduce thermal volatilisation of terpenes like myrcene, limonene, and alpha-pinene. That said, downstream processing steps — including solvent evaporation — can still introduce thermal stress even when the initial extraction was cold. The full process chain matters, not just the extraction step in isolation.

What is decarboxylation and why does it matter for cannabinoid extracts?

Decarboxylation is a chemical reaction in which a carboxyl group is removed from a molecule, typically releasing CO₂. In cannabis plant material, THCA (the acidic precursor) converts to THC, and CBDA converts to CBD, through this process when exposed to sufficient heat. Hot extraction methods trigger this conversion; cold extraction largely preserves the acidic forms. The two forms have different chemical properties and different receptor interaction profiles, so which form dominates in a finished extract depends heavily on whether heat was applied.

Is supercritical CO₂ extraction considered a cold process?

Not quite, despite how it's sometimes described. CO₂ reaches its supercritical state at around 31°C and 73.8 bar, and practical cannabinoid extraction often runs at 40–60°C. That's well below the temperatures associated with hot solvent methods, but it's not cryogenic. Some decarboxylation and terpene volatilisation can still occur over a long extraction run. Subcritical CO₂ conditions — lower temperature and pressure — are more selective for terpenes and lighter compounds.

How does extraction temperature affect minor cannabinoids like CBG and THCV?

Minor cannabinoids typically occur at lower concentrations than CBD or THC in most cultivars, which means any processing loss is proportionally larger. High-temperature extraction or prolonged heat exposure during solvent removal can degrade or convert these compounds before they're captured in the final extract. Cold-process methods are generally better at retaining the minor cannabinoid diversity that contributes to a full-spectrum profile.

Why does any of this matter for regulated medicinal cannabis products in Australia?

Under the TGA's framework, a medicinal cannabis product must meet the quality specification listed in its ARTG entry, and that specification includes cannabinoid and terpene content. GMP-compliant manufacturers are required to validate and document their extraction processes — including temperature parameters — to ensure batch-to-batch consistency. The extraction method therefore has a direct bearing on whether a product meets its approved specification and can legally be supplied under the Special Access Scheme or via an Authorised Prescriber.

Cold vs Hot Extraction Methods

By Tom Whitfield · 22 May 2026 · 7 min read

Temperature is a variable, not a detail

Somewhere around 105°C, THCA starts converting to THC. That single fact, a consequence of a decarboxylation reaction most organic chemistry students encounter in their first year, underpins an enormous amount of the practical debate about how cannabinoid-rich plant material is processed. And yet the broader question , cold versus hot extraction, and what it actually does to the chemical profile of the finished preparation , tends to get flattened into a much simpler story than the science warrants.

I've been building the reference library for this site for a while now, and the extraction literature is one of those areas where I keep finding researchers talking past one another because they're optimising for different things. A pharmaceutical scientist chasing a pure isolate and a formulator trying to preserve a full-spectrum profile are both right about what they're doing. They just have different goals.

So let's look at what the chemistry actually says.

What cold extraction is trying to protect

Cold extraction methods , which include low-temperature ethanol extraction (often conducted at or below −40°C), cold-press mechanical techniques, and ice-water separation; are designed around a straightforward premise: volatiles evaporate, heat degrades, and some molecules you want in the final product won't survive anything warmer than a Brisbane winter morning.

Terpenes are the obvious concern. Compounds like myrcene, limonene, and linalool have boiling points ranging from roughly 167°C down to about 198°C, but they begin volatilising meaningfully well below those figures. Beta-caryophyllene, which is notable for its interaction with CB2 receptors, is somewhat more heat-stable than the monoterpenes, but it still degrades under sustained thermal exposure. Cold extraction attempts to keep these compounds intact in the final product.

There's also the matter of the acidic cannabinoid precursors. CBDA and THCA, the raw, pre-decarboxylated forms of CBD and THC respectively, are present in fresh or dried but unheated plant material. Some researchers have been investigating their distinct receptor interaction profiles, which differ from their neutral counterparts. Cold extraction is essentially the only way to preserve them at meaningful concentrations.

A 2021 review in Molecules (MDPI) noted that cryogenic ethanol extraction at −40°C or below substantially reduced co-extraction of chlorophylls and waxes, while simultaneously improving retention of both terpene and minor cannabinoid content compared to ambient-temperature solvent methods. The short version: cold is selective in useful ways.

What heat actually does to a cannabinoid profile

Decarboxylation is the main event, and it's worth being precise about it. THCA loses its carboxyl group (as CO₂) to become THC. CBDA becomes CBD. CBGA converts to CBG. The temperature and duration interact: a lower temperature held for longer produces a different decarboxylation curve than a higher temperature held briefly. Industrial hot extraction processes need to account for this if they want a reproducible cannabinoid profile in the finished extract.

But decarboxylation is not the only thing heat does. Past certain thresholds, THC itself begins converting to CBN through an oxidative degradation pathway. CBN is a minor cannabinoid present in aged or improperly stored material, and its presence in an extract at elevated concentrations is generally a signal of thermal stress, not intentional formulation. Similarly, prolonged or high-temperature processing can degrade smaller-yield cannabinoids like THCV and CBG before they've had a chance to contribute meaningfully to the extract's profile.

Terpene loss under heat is well-documented. Alpha-pinene, for instance, has a boiling point of approximately 155°C but will volatilise significantly during any warm solvent evaporation step. Formulators who want a genuinely terpene-rich extract; one that may have bearing on what's often called the entourage effect, face a real trade-off when they apply heat during processing.

Supercritical CO₂: the middle ground that isn't quite neutral

Supercritical CO₂ (scCO₂) extraction gets promoted as a temperature-controlled alternative because the critical point of CO₂ is reached at around 31°C and 73.8 bar. At subcritical conditions (lower temperature, lower pressure), scCO₂ is relatively selective for terpenes and lighter compounds. Raise the pressure and temperature into supercritical range and you get better cannabinoid extraction.

I'd argue the "cold" framing that sometimes gets applied to CO₂ extraction in popular writing is a bit misleading. The temperatures involved, often 40–60°C in practice for cannabinoid extraction; aren't hot-process hot, but they're not genuinely cold either. The decarboxylation rate at those temperatures over a prolonged run is real, even if modest. The literature is sometimes imprecise about this distinction, and I think it matters for anyone trying to understand what's actually in a standardised extract.

Solvent choice intersects with temperature

Temperature and solvent interact in ways that compound the extraction chemistry. Ethanol is polar enough to co-extract chlorophylls, water-soluble pigments, and some plant waxes at ambient temperatures; cooling it dramatically reduces this co-extraction, which is why cryogenic ethanol is a more refined starting point for a clean oil. Hydrocarbon solvents (butane, propane) are used at very low temperatures by design and are highly selective for cannabinoids and terpenes but leave almost no acidic precursors behind because even "cold" hydrocarbon runs often involve a post-extraction purge step that applies mild heat.

For broad-spectrum and full-spectrum products, the solvent-temperature combination is arguably the single most important quality variable before any downstream refinement happens. A Good Manufacturing Practice-compliant facility will validate and document their solvent temperature profiles precisely because the resulting cannabinoid and terpene distribution is what the ARTG-listed specification is built around.

Between a cryptic crossword clue I was stuck on last Tuesday and a deep dive into a 2019 paper on ethanol polarity shifts under cryogenic conditions, I genuinely lost an evening. The crossword stayed unsolved. The paper was worth it.

What this means for minor cannabinoids and terpenes

Minor cannabinoids are disproportionately affected by thermal processing choices. CBG and THCV are present in relatively low concentrations in most cultivars. CBC, CBDV, and trace compounds like CBGA sit at even lower concentrations. Any processing loss is magnified proportionally when you're starting from a small baseline.

Similarly, less-studied sesquiterpenes like nerolidol, bisabolol, and humulene have distinct thermal stability profiles from the major monoterpenes. A hot-process extract won't eliminate them entirely, but the ratio between terpene classes in the finished oil will look different from a cold-process extract starting from the same raw material. Whether that ratio matters for the extract's final chemical character, and how it interacts with the endocannabinoid system, is still an active area of research.

Regulatory and quality framing in Australia

Under the TGA's manufacturing framework, any medicinal cannabis product supplied in Australia must meet the relevant quality standards set out in the Therapeutic Goods (Standard for Medicinal Cannabis) Determination 2017. GMP-compliant extraction facilities are required to document and validate their processes, which includes temperature parameters. This isn't optional paperwork; it's the mechanism by which a specification in an ARTG listing can be reliably reproduced batch to batch.

Extraction method directly shapes cannabinoid profile, and cannabinoid profile is what's listed on an approved product's specification. A product assessed under the Special Access Scheme or prescribed by an Authorised Prescriber is supposed to be chemically consistent across supply. That consistency begins in the extraction room, with temperature control.

Understanding the extraction chemistry is also relevant to interpreting certificate of analysis (CoA) data; the cannabinoid and terpene panel that reputable manufacturers publish for each batch. If a CoA shows very low acidic cannabinoid content and a compressed terpene profile, that's a hot-process signature. Neither good nor bad on its own terms, but meaningful context.

Sources

, Tom Whitfield, Health librarian, references & fact-checking

Common questions

Does cold extraction always preserve more terpenes than hot extraction?: Generally yes, but it depends on the specific method and solvent. Cryogenic ethanol and ice-water separation techniques are designed to reduce thermal volatilisation of terpenes like myrcene, limonene, and alpha-pinene. That said, downstream processing steps — including solvent evaporation — can still introduce thermal stress even when the initial extraction was cold. The full process chain matters, not just the extraction step in isolation.
What is decarboxylation and why does it matter for cannabinoid extracts?: Decarboxylation is a chemical reaction in which a carboxyl group is removed from a molecule, typically releasing CO₂. In cannabis plant material, THCA (the acidic precursor) converts to THC, and CBDA converts to CBD, through this process when exposed to sufficient heat. Hot extraction methods trigger this conversion; cold extraction largely preserves the acidic forms. The two forms have different chemical properties and different receptor interaction profiles, so which form dominates in a finished extract depends heavily on whether heat was applied.
Is supercritical CO₂ extraction considered a cold process?: Not quite, despite how it's sometimes described. CO₂ reaches its supercritical state at around 31°C and 73.8 bar, and practical cannabinoid extraction often runs at 40–60°C. That's well below the temperatures associated with hot solvent methods, but it's not cryogenic. Some decarboxylation and terpene volatilisation can still occur over a long extraction run. Subcritical CO₂ conditions — lower temperature and pressure — are more selective for terpenes and lighter compounds.
How does extraction temperature affect minor cannabinoids like CBG and THCV?: Minor cannabinoids typically occur at lower concentrations than CBD or THC in most cultivars, which means any processing loss is proportionally larger. High-temperature extraction or prolonged heat exposure during solvent removal can degrade or convert these compounds before they're captured in the final extract. Cold-process methods are generally better at retaining the minor cannabinoid diversity that contributes to a full-spectrum profile.
Why does any of this matter for regulated medicinal cannabis products in Australia?: Under the TGA's framework, a medicinal cannabis product must meet the quality specification listed in its ARTG entry, and that specification includes cannabinoid and terpene content. GMP-compliant manufacturers are required to validate and document their extraction processes — including temperature parameters — to ensure batch-to-batch consistency. The extraction method therefore has a direct bearing on whether a product meets its approved specification and can legally be supplied under the Special Access Scheme or via an Authorised Prescriber.